国药控股与华润医药两大千亿药商发布了2024年业绩报告。国药控股营收5845.08亿元，同比下降2.02%，归母净利润70.50亿元，下降22.14%；华润医药营收2576.73亿元，增长5.3%，归母净利润33.51亿元，减少13.1%。国药控股的医药分销、器械分销、医药零售及其他业务分别增长0.75%、-9.44%、0.82%和-12.32%，而华润医药的医药分销、制药及药品零售则分别增长...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.